RE:RE:RE:RE:RE:RE:2018 AGM Uplist to Another Exchange"How can someone who presents like that close ANY deals?!!"
Gilles has created a perfect resume in support of deals. C$20 billion market cap Symrise has, in fact, complemented the long-standing product development relationship it has with CZO.
“Ceapro and Symrise have a long-standing relationship in product development that has benefitted both companies over the years,” said Joern Andreas, President Cosmetic Ingredients Division, Symrise AG. “We see great value in this partnership and are very pleased to have secured this agreement, which will continue to pave the way for future developments that I believe will benefit both companies in creating value.” CZO News Release
CZO's bioactives are used by many leading brands such as Aveeno, Neutrogena, and Gold Bond. CZO also operates a state-of-the-art plant that has past inspections by the likes of J&J and Sanofi.
CZO's science has further been supported by significant funding from the Canadian government. Opinion leaders such as Dr. Martin Kolb and Dr. Kjetil Ask has expressed their excitement concerning the science. The Montreal Heart Institute is conducting CZO's Phase I/IIa avenanthramide clinical trial. CZO's technology has been measured against the gold standard as for CoQ10 bioavailability at the University of Alberta. CZO's science has been peer-reviewed in numerous publications.